Page 11 - Dan Budwick News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Leading scientific and clinical experts to provide perspectives and rationale for TREM2 and progranulin targets on December 7 and December 13, respectivelySOUTH SAN FRANCISCO, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company pioneering immuno-neurology, today announced management will host two virtual events in December to discuss the Company’s TREM2 and progranulin (PGRN) programs. The events will include presentations from Alector’s managem

14.11.2023 - SAN DIEGO, Nov. 14, 2023 (GLOBE NEWSWIRE) - Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today highlighted recent ...

CAMBRIDGE, Mass., Nov. 08, 2023 -- Beam Therapeutics Inc. , a biotechnology company developing precision genetic medicines through base editing, today announced that John Evans, chief executive...

Relay Therapeutics to Participate in Stifel 2023 Healthcare Conference ...

– Both Mitapivat Dose Arms Achieved Statistically Significant Hemoglobin Response in Phase 2 Portion of RISE UP Pivotal Study in Sickle Cell Disease, Compared to the Placebo Arm; Data Support